COVID-19:CT能否提供最佳人群水平生物标志物?重大创伤患者中的偶发COVID-19提示伦敦感染率高于预期
本研究评估2020年1月1日至4月30日因重大创伤入院且CT包含肺部的523例患者的偶发COVID-19表现,并以2019年1月和3月入院252例为对照组,采用双读共识盲法判断。结果显示符合COVID-19的CT表现自2月第二周起超过基线并持续至封控后2周才下降,至2020年4月底约45%人群已感染。作者认为重大创伤患者CT可用于监测COVID-19传播。
要点
- 重大创伤患者CT可显示偶发COVID-19表现,双读共识盲法用于判断。
- CT表现自2月第二周起超过COVID-19前基线,封控后2周才下降。
- 至2020年4月底估计约45%人群已感染COVID-19。
核心结论
- 重大创伤患者的CT可用于监测COVID-19传播。
- 该新技术可在任何有创伤扫描的地方回顾性或前瞻性用于监测当地人群疾病。
研究设计与样本
- 研究纳入2020年1月1日至4月30日因重大创伤入院且CT包含肺部的所有患者(n=523)。
- 对照组为2019年1月1日至31日和2019年3月1日至31日COVID-19前入院的重大创伤患者(n=252)。
- 评估放射科医生对时间段盲法,采用双读共识判断患者是否有COVID-19的CT征象。
- 肺部表现分为无COVID-19证据、轻微征象或主要征象三类。
关键影像表现/征象
- 符合COVID-19的CT表现自2月第二周开始超过COVID-19前背景率,直至封控后2周才下降。
- 肺部表现按无COVID-19证据、轻微征象、主要征象分类记录。
诊断标准与关键数值
- 采用双读共识将肺部CT表现分为无COVID-19证据、轻微征象或主要征象。
- 记录研究期间偶发COVID-19改变的患者比例,并估计至2020年4月底受COVID-19影响的人群百分比。
临床应用与阅片要点
- 作者认为重大创伤患者CT可用于监测COVID-19传播。
- 作者认为该技术可在任何有创伤扫描的地方回顾性或前瞻性用于监测当地人群疾病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate incidental findings in major trauma patients, and to explore whether computed tomography (CT) could be used to assess prevalence and estimate disease spread in the general population.
MATERIALS AND METHODS: The study population included all patients admitted following major trauma between 1 January 2020 and 30 April 2020 with CT including the lungs (n=523). Major trauma patients admitted pre-COVID-19 from 1-31 January and 1-31 March 2019 comprised a control group (n=252). The assessing radiologists, blinded to the time period, used double reading with consensus to determine if the patient had CT signs of COVID-19. Lung appearances were classified as no evidence of COVID-19; minor signs; or major signs. The proportion of patients with incidental COVID-19 changes was recorded over the study period, and the percentage of the population who had been affected by COVID-19 by the end of April 2020 estimated.
RESULTS: CT appearances consistent with COVID-19 began to exceed a background pre-COVID rate in the second week of February and did not decline until 2 weeks after lockdown. By the end of April 2020, approximately 45% of the population had been infected.
CONCLUSIONS: CT of major trauma patients can be used to monitor the spread of COVID-19. This novel technique could be used retrospectively or prospectively anywhere where trauma scans are available, to monitor the disease in the local population.
引用
- Adam EJ, Grubnic S, Jacob TM, et al. COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London. Clin Radiol. 2020. PMID: 33246570. doi:10.1016/j.crad.2020.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。